BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24863399)

  • 1. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.
    Kanazawa H; Yoshida N; Shinnabe A; Iino Y
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):88-92. PubMed ID: 24863399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y; Usubuchi H; Kodama K; Kanazawa H; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
    Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
    Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H; Yoshida N; Yamamoto H; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Iino Y
    Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media.
    Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
    Otol Neurotol; 2012 Sep; 33(7):1218-24. PubMed ID: 22825324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of IgE in eosinophilic otitis media.
    Iino Y
    Allergol Int; 2010 Sep; 59(3):233-238. PubMed ID: 20657163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Insights into Eosinophilic Otitis Media.
    Kanazawa H; Yoshida N; Iino Y
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media.
    Uchimizu H; Matsuwaki Y; Kato M; Otori N; Kojima H
    Allergol Int; 2015 Sep; 64 Suppl():S18-23. PubMed ID: 26344075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma.
    Iino Y; Nagamine H; Yabe T; Matsutani S
    Clin Exp Allergy; 2001 Jul; 31(7):1135-43. PubMed ID: 11468006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.
    Iino Y; Tomioka-Matsutani S; Matsubara A; Nakagawa T; Nonaka M
    Auris Nasus Larynx; 2011 Aug; 38(4):456-61. PubMed ID: 21251776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Nagamine H; Kakizaki K; Komiya T; Katano H; Saruya S; Kodera K
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
    Iino Y; Takahashi E; Ida S; Kikuchi S
    Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
    Iino Y; Usubuchi H; Kodama K; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and antigen- (fungi, mites and staphylococcal enterotoxins) specific IgEs in nasal polyps is related to local eosinophilic inflammation.
    Matsuwaki Y; Uno K; Okushi T; Otori N; Moriyama H
    Int Arch Allergy Immunol; 2013; 161 Suppl 2():147-53. PubMed ID: 23711866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of so called eosinophilic otitis media.
    Nagamine H; Iino Y; Kojima C; Miyazawa T; Iida T
    Auris Nasus Larynx; 2002 Jan; 29(1):19-28. PubMed ID: 11772486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry.
    Iino Y; Kakizaki K; Saruya S; Katano H; Komiya T; Kodera K; Ohta K
    Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1109-14. PubMed ID: 17043260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion.
    Nonaka M; Fukumoto A; Ozu C; Mokuno E; Baba S; Pawankar R; Yagi T
    Acta Otolaryngol; 2003 Apr; 123(3):383-7. PubMed ID: 12737295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant.
    Han YE; Kang YS; Cho Y; Park MK
    J Int Adv Otol; 2018 Apr; 14(1):144-147. PubMed ID: 29764789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.